A collaboration between the Department of Ophthalmology and POWER (PA Organization for Women in Early Recovery) resulted in the first outdoor mobile optometry clinic. “The event was a success,” said […]
A collaboration between the Department of Ophthalmology and POWER (PA Organization for Women in Early Recovery) resulted in the first outdoor mobile optometry clinic. “The event was a success,” said […]
Dear Friends and Colleagues, As we move through the summer, I am filled with gratitude and pride at what our Department has accomplished — and profound optimism for what lies […]
Thanks to a $100,000 grant, radiofrequency therapy (RF) is now available in the Vision Institute’s Dry Eye Clinic. RF is an FDA approved therapy for dry eye disease that utilizes […]
Read More… from Radiofrequency Therapy Now Available in Dry Eye Clinic
Jose-Alain Sahel, MD, Chairman of the Department of Ophthalmology and Director of the UPMC Vision Institute, and Maysam Chamanzar, PhD, Dr. William D. and Nancy W. Strecker Career Development Professor, […]
Read More… from Partnership to Develop Breakthrough Imaging Platform
Marlene Behrmann, PhD, John and Clelia Sheppard Chair in Ophthalmology at the University of Pittsburgh, is receiving an Honorary Doctorate from the University of Copenhagen in the fall. Dr. Behrmann […]
During the first year Daniel Gao, PhD, was at Pitt, he was fortunate to build a team of researchers with diverse backgrounds who share a passion for understanding fundamental biological […]
José-Alain Sahel, MD, FARVO, Distinguished Professor and Chair of the Department of Ophthalmology at the University of Pittsburgh School of Medicine, the Eye & Ear Foundation Chair, and Director of […]
The lab of Boris Rosin, MD, PhD, focuses on the neuronal activity correlates of visual disability, both in the retina and the central nervous system (CNS), and their implications for […]
Read More… from Improving Visual Rehabilitation and Treatment Outcomes
Dr. Joseph Martel’s work focuses on inherited retinal diseases (IRDs), a group of rare, often devastating conditions that cause progressive vision loss and for which there have historically been no […]
Read More… from Investigating Potential Treatments for Rare IRDs
Targeted mutation correction is well-suited to treat genetic diseases in which many patients have a small number of mutations. But many genetic diseases are caused by large numbers of pathogenic […]
Read More… from Developing Mutation and Gene-Agnostic Editing Strategies
The Systems Pharmacology Lab of Retinal Degenerationof Yuanyuan, run by Yuanyuan Chen, PhD, focuses on pharmacological studies of inherited retinal disease and age-related retinal degeneration. The lab develops drug screening […]
Read More… from Developing New Drug Candidates for Retinal Diseases